Ferramentas Pessoais
Acções do Documento

Doctors

Subir um nível

Loading in progress...

The non-invasive tests,
alternative to liver biopsy



BioPredictive markets non-invasive tests (blood test) for a diagnosis and prognosis of liver diseases.


BioPredictive
FibroTest
For hepatitis B
and hepatitis C		 FibroMax
For hepatitis, alcohol
and metabolism

  • For hepatitis B: FibroTest

    For hepatitis B, the test assesses liver fibrosis but also necroinflammatory activity:

    • FibroTest
      F=0.24 (F1)
      Minimal fibrosis
      Estimates liver fibrosisFibroTest
    • ActiTest
      A=0.48 (A1)
      Moderate activity
      Estimates the necroinflammatory activityActiTest
    To find out more

  • For hepatitis C: FibroTest

    For hepatitis C, the test assesses liver fibrosis but also necroinflammatory activity:

    • FibroTest
      F=0.24 (F1)
      Minimal fibrosis
      Estimates liver fibrosisFibroTest
    • ActiTest
      A=0.48 (A1)
      Moderate activity
      Estimates the necroinflammatory activityActiTest
    To find out more

  • Alcohol: FibroMax

    For the excessive consumption of alcohol: FibroMax is an appropriate combination of our tests which assesses not only fibrosis (FibroTest) but also steatosis (SteatoTest, estimation of the fatty liver) and steatohepatitis (AshTest, estimation of acute alcoholic hepatitis):

    • FibroTest
      F=0.24 (F1)
      Minimal fibrosis
      Estimates liver fibrosisFibroTest
    • SteatoTest
      S=0.48 (S1)
      Minimal steatosis
      Estimates the steatohepatitis of the liverSteatoTest
    • AshTest
      H=0.48 (H1)
      Minimal ASH
      Estimates alcoholic steatohepatitis of the liverAshTest
    To find out more

  • Metabolic: FibroMax

    For the metabolic diseases (overweight, diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension): FibroMax is an appropriate combination of our tests which assesses not only fibrosis (FibroTest) but also steatosis (SteatoTest, estimation of the fatty liver) and steatohepatitis (NashTest, estimation of non-alcoholic steatohepatitis):

    • FibroTest
      F=0.24 (F1)
      Minimal fibrosis
      Estimates liver fibrosisFibroTest
    • SteatoTest
      S=0.48 (S1)
      Minimal steatosis
      Estimates the steatohepatitis of the liverSteatoTest
    • NashTest
      N=No-Nash (N0)
      No NASH
      Estimates non-alcoholic steatohepatitis of the liverNashTest
    To find out more

Welcome to BioPredictive

Non-invasive liver diagnostic tests.

Learn more

Endereço

BioPredictive
40 rue du Bac
75007 Paris
FRANCE

Tel : +33 1 45 44 30 64
email : contact@biopredictive.com


Come meet us

    22-25 may National Congress of Romanian Society of Diabetes, Nutrition and Metabolic Diseases (Sibiu, Romania)
    23-25 may Regional Conference of Family Medicine (Cluj; Romania)
    5-8 jun 2nd Congress of RAML (Brasov, Romania)
    12-15 jun The 33rd National Symposium of Hepatology (Romania; Timisoara)
    29-30 jun Control Diabetes National Campaign (Romania; Suceava)
    23-26 oct National Conference of Family Medicine (Bucharest, Romania)
    23-25 oct INBI Matei Bals Institute Days (Bucharest, Romania)
    23-24 oct Days of the Central Military Hospital (Bucharest; Romania)
    5-8 nov The 11th Congress of the Romanian Diabetes (Iasi; Romania)
Upcoming events…
 
Feito com Plone CMS, o Software Livre para Gestão de Conteúdos

Este sítio está em conformidade com as seguintes normas: